JPRN-UMIN000023805已完成未知
Effects of pioglitazone on bone formation and resorption markers in type 2 diabetes mellitus. - Effects of pioglitazone on bone
niversity of Occupational and Environmental Health, Japan0 个研究点目标入组 60 人开始时间: 2016年8月29日最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 80years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients treated with pioglitazone, metformin or insulin, with type 1 diabetes, history of secondary osteoporosis, heart failure, renal failure, liver failure, and patients receiving any drugs that affect bone metabolism (bisphosphonates, vitamin K, estrogen, calcium, anabolic steroids, or male and female hormones) were excluded from the research.
研究者
相似试验
已完成
不适用
Effects of pioglitazone or metformin on bone markers and bone mineral density as well as parameters of atherosclerosis in patients with type 2 diabetesType 2 diabetes mellitusJPRN-UMIN000001997Department of Internal Medicine 1, Shimane University School of Medicine60
进行中（未招募）
不适用
The effect of glitazone-treatment on bone turn-over and bone marrow cellsWe want to investigate if rosiglitazone treatment can induce bone loss in humansMedDRA version: 9.1Level: LLTClassification code 10031289Term: Osteoporosis, unspecifiedEUCTR2007-004714-14-DKAarhus University Hospital, Aarhus Sygehus
已完成
4 期
Efficacy of Pioglitazone on Bone Metabolism in Postmenopausal Women With Impaired Fasting Glucose.Bone MetabolismNCT00708175Takeda156
已完成
4 期
Effects of Rosiglitazone on Bone in Postmenopausal Diabetic WomenObesityType 2 Diabetes MellitusMenopauseNCT00440375Baskent University82
已完成
2 期
Effect of Pioglitazone Versus Metformin on Bone Health in Postmenopausal Women With Type 2 DiabetesGlucose Metabolism DisordersDiabetes Mellitus, Type 2Diabetes MellitusNCT01935804King Abdulaziz University440